{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:40:16Z","timestamp":1780659616051,"version":"3.54.1"},"reference-count":105,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002985","name":"Delhi Technological University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neurodegenerative disorders (NDDs) are known to exhibit genetic overlap and shared pathophysiology. This study aims to find the shared genetic architecture of Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), two major age-related progressive neurodegenerative disorders. The gene expression profiles of GSE67333 (containing samples from AD patients) and GSE114517 (containing samples from PD patients) were retrieved from the Gene Expression Omnibus (GEO) functional genomics database managed by the National Center for Biotechnology Information. The web application GREIN (GEO RNA-seq Experiments Interactive Navigator) was used to identify differentially expressed genes (DEGs). A total of 617 DEGs (239 upregulated and 379 downregulated) were identified from the GSE67333 dataset. Likewise, 723 DEGs (378 upregulated and 344 downregulated) were identified from the GSE114517 dataset. The protein\u2013protein interaction networks of the DEGs were constructed, and the top 50 hub genes were identified from the network of the respective dataset. Of the four common hub genes between two datasets, C-X-C chemokine receptor type 4 (CXCR4) was selected due to its gene expression signature profile and the same direction of differential expression between the two datasets. Mavorixafor was chosen as the reference drug due to its known inhibitory activity against CXCR4 and its ability to cross the blood\u2013brain barrier. Molecular docking and molecular dynamics simulation of 51 molecules having structural similarity with Mavorixafor was performed to find two novel molecules, ZINC49067615 and ZINC103242147. This preliminary study might help predict molecular targets and diagnostic markers for treating Alzheimer\u2019s and Parkinson\u2019s diseases.<\/jats:p>\n               <jats:p>Insight Box Our research substantiates the therapeutic relevance of CXCR4 inhibitors for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases. We would like to disclose the following insights about this study. We found common signatures between Alzheimer\u2019s and Parkinson\u2019s diseases at transcriptional levels by analyzing mRNA sequencing data. These signatures were used to identify putative therapeutic agents for these diseases through computational analysis. Thus, we proposed two novel compounds, ZINC49067615 and ZINC103242147, that were stable, showed a strong affinity with CXCR4, and exhibited good pharmacokinetic properties. The interaction of these compounds with major residues of CXCR4 has also been described.<\/jats:p>","DOI":"10.1093\/intbio\/zyad012","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:19:29Z","timestamp":1693196369000},"source":"Crossref","is-referenced-by-count":5,"title":["Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer\u2019s and Parkinson\u2019s diseases"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5587-0888","authenticated-orcid":false,"given":"Rahul","family":"Tripathi","sequence":"first","affiliation":[{"name":"Department of Biotechnology , Molecular Neuroscience and Functional Genomics Laboratory, , Delhi , India"},{"name":"Delhi Technological University (Formerly Delhi College of Engineering) , Molecular Neuroscience and Functional Genomics Laboratory, , Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-2344","authenticated-orcid":false,"given":"Pravir","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology , Molecular Neuroscience and Functional Genomics Laboratory, , Delhi , India"},{"name":"Delhi Technological University (Formerly Delhi College of Engineering) , Molecular Neuroscience and Functional Genomics Laboratory, , Delhi , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"2023082804052294200_ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41398-017-0049-7","article-title":"CXCR4 involvement in neurodegenerative diseases","volume":"8","author":"Bonham","journal-title":"Transl Psychiatry"},{"key":"2023082804052294200_ref2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","article-title":"Progressive supranuclear palsy: pathology and genetics","volume":"17","author":"Dickson","year":"2007","journal-title":"Brain Pathol"},{"key":"2023082804052294200_ref3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2023082804052294200_ref4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"2023082804052294200_ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"2023082804052294200_ref6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat Genet"},{"key":"2023082804052294200_ref7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"2023082804052294200_ref8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"377","author":"Nalls","year":"2011","journal-title":"Lancet"},{"key":"2023082804052294200_ref9","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001273R","article-title":"Polyfunctionality of the CXCR4\/CXCL12 axis in health and disease: implications for therapeutic interventions in cancer and immune-mediated diseases","volume":"35","author":"Britton","year":"2021","journal-title":"FASEB J"},{"key":"2023082804052294200_ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.stem.2010.05.019","article-title":"Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1\/CXCR4 signaling","volume":"7","author":"Kokovay","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2023082804052294200_ref11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2004.04.002","article-title":"Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity","volume":"25","author":"Klein","year":"2004","journal-title":"Trends Immunol"},{"key":"2023082804052294200_ref12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"key":"2023082804052294200_ref13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/89490","article-title":"CXCR4-activated astrocyte glutamate release via TNF\u03b1: amplification by microglia triggers neurotoxicity","volume":"4","author":"Bezzi","year":"2001","journal-title":"Nat Neurosci"},{"key":"2023082804052294200_ref14","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/cdd.2008.95","article-title":"The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein","volume":"15","author":"Khan","year":"2008","journal-title":"Cell Death Differ"},{"key":"2023082804052294200_ref15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/13550280390201010","article-title":"The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons","volume":"9","author":"Khan","year":"2003","journal-title":"J Neurovirol"},{"key":"2023082804052294200_ref16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/bc.bc_13_17","article-title":"A focus on CXCR4 in Alzheimer\u2019s disease","volume":"3","author":"Li","year":"2017","journal-title":"Brain Circ"},{"key":"2023082804052294200_ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1646-6","article-title":"CXCL12 is involved in \u03b1-synuclein-triggered neuroinflammation of Parkinson\u2019s disease","volume":"16","author":"Li","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2023082804052294200_ref18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-60327-216-2_23","article-title":"Structure-based functional design of drugs: from target to lead compound","volume":"823","author":"Anderson","year":"2012","journal-title":"Methods Mol Biol"},{"key":"2023082804052294200_ref19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/1570159X15666171016163510","article-title":"Computer aided drug design and its application to the development of potential drugs for neurodegenerative disorders","volume":"16","author":"Baig","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"2023082804052294200_ref20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","article-title":"Computer-aided drug design methods","volume":"1520","author":"Yu","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2023082804052294200_ref21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/1570159X16666180315142137","article-title":"Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design","volume":"16","author":"Sehgal","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"2023082804052294200_ref22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","article-title":"Use of molecular docking computational tools in drug discovery","volume":"60","author":"Stanzione","year":"2021","journal-title":"Prog Med Chem"},{"key":"2023082804052294200_ref23","first-page":"207","article-title":"Computational approaches in drug designing","volume":"2022","author":"Tiwari","year":"2022","journal-title":"Bioinforma Methods Appl"},{"key":"2023082804052294200_ref24","doi-asserted-by":"crossref","first-page":"D562","DOI":"10.1093\/nar\/gki022","article-title":"NCBI GEO: mining millions of expression profiles\u2014database and tools","volume":"33","author":"Barrett","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2023082804052294200_ref25","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"2023082804052294200_ref26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2023082804052294200_ref27","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20 - a free Ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J Chem Inf Model"},{"key":"2023082804052294200_ref28","first-page":"1","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Chem"},{"key":"2023082804052294200_ref29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drudis.2010.11.002","article-title":"The graphical representation of ADME-related molecule properties for medicinal chemists","volume":"16","author":"Ritchie","year":"2011","journal-title":"Drug Discov Today"},{"key":"2023082804052294200_ref30","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"2023082804052294200_ref32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin Drug Discovery"},{"key":"2023082804052294200_ref33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.21494","article-title":"Calculation of molecular lipophilicity: state-of-the-art and comparison of log P methods on more than 96,000 compounds","volume":"98","author":"Mannhold","year":"2009","journal-title":"J Pharm Sci"},{"key":"2023082804052294200_ref34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"key":"2023082804052294200_ref35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/ci200387c","article-title":"Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"52","author":"Ali","year":"2012","journal-title":"J Chem Inf Model"},{"key":"2023082804052294200_ref36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2015.03.001","article-title":"Prediction of drug-ABC-transporter interaction\u2014recent advances and future challenges","volume":"86","author":"Montanari","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"2023082804052294200_ref37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0091270007312153","article-title":"New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process","volume":"48","author":"Huang","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"2023082804052294200_ref38","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acs.jcim.8b00934","article-title":"Predicting skin permeability by means of computational approaches: reliability and caveats in pharmaceutical studies","volume":"59","author":"Pecoraro","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2023082804052294200_ref39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat Chem"},{"key":"2023082804052294200_ref40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"2023082804052294200_ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J Comb Chem"},{"key":"2023082804052294200_ref42","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref43","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref44","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref45","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref46","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"2023082804052294200_ref47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"2023082804052294200_ref48","first-page":"8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J Chem"},{"key":"2023082804052294200_ref49","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"2023082804052294200_ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/147648","article-title":"Protein-protein interaction detection: methods and analysis","volume":"2014","author":"Rao","year":"2014","journal-title":"Int J Proteomics"},{"key":"2023082804052294200_ref51","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2023082804052294200_ref52","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2023082804052294200_ref53","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"2023082804052294200_ref54","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s10571-021-01115-1","article-title":"The CXCL12\/CXCR4\/ACKR3 response axis in chronic neurodegenerative disorders of the central nervous system: therapeutic target and biomarker","volume":"42","author":"Yan","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"2023082804052294200_ref55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2006.06.016","article-title":"Inhibition of Wnt signaling, modulation of tau phosphorylation and induction of neuronal cell death by DKK1","volume":"24","author":"Scali","year":"2006","journal-title":"Neurobiol Dis"},{"key":"2023082804052294200_ref56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2012.07.030","article-title":"Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats","volume":"525","author":"Dun","year":"2012","journal-title":"Neurosci Lett"},{"key":"2023082804052294200_ref57","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/stem.80","article-title":"Activin a is essential for neurogenesis following neurodegeneration","volume":"27","author":"Abdipranoto-Cowley","year":"2009","journal-title":"Stem Cells"},{"key":"2023082804052294200_ref58","doi-asserted-by":"crossref","first-page":"113412","DOI":"10.1016\/j.expneurol.2020.113412","article-title":"Knockdown of follistatin-like 1 disrupts synaptic transmission in hippocampus and leads to cognitive impairments","volume":"333","author":"Xiang","year":"2020","journal-title":"Exp Neurol"},{"key":"2023082804052294200_ref59","doi-asserted-by":"crossref","first-page":"147127","DOI":"10.1016\/j.brainres.2020.147127","article-title":"Postsynaptic damage and microglial activation in AD patients could be linked CXCR4\/CXCL12 expression levels","volume":"1749","author":"Sanfilippo","year":"2020","journal-title":"Brain Res"},{"key":"2023082804052294200_ref60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease","volume":"25","author":"Bagheri","year":"2019","journal-title":"Neuroimmunomodulation"},{"key":"2023082804052294200_ref61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/1673-5374.314303","article-title":"Inhibition of CXCR4\/CXCL12 signaling: a translational perspective for Alzheimer\u2019s disease treatment","volume":"17","author":"Gavriel","year":"2022","journal-title":"Neural Regen Res"},{"key":"2023082804052294200_ref62","article-title":"HMGB1 a box binds to CXCR4 to inhibit HMGB1\/CXCL12 mediating macrophage and T cell infiltration and prevents neuronal damage in Parkinson\u2019s disease","volume":"2022","author":"Tian","year":"2022","journal-title":"Authorea Prepr"},{"key":"2023082804052294200_ref63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2023082804052294200_ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s disease with the alpha-Synuclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023082804052294200_ref65","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1111\/bph.14593","article-title":"Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy","volume":"176","author":"Nalivaeva","year":"2019","journal-title":"Br J Pharmacol"},{"key":"2023082804052294200_ref66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-Synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"2023082804052294200_ref67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155295","article-title":"The functional roles and applications of immunoglobulins in neurodegenerative disease","volume":"21","author":"Sim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023082804052294200_ref68","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1084\/jem.20140457","article-title":"CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow","volume":"211","author":"Beck","year":"2014","journal-title":"J Exp Med"},{"key":"2023082804052294200_ref69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ibra.12026","article-title":"Research progress of the CXCR4 mechanism in Alzheimer\u2019s disease","volume":"8","author":"Wang","year":"2022","journal-title":"Ibrain"},{"key":"2023082804052294200_ref70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","article-title":"Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues","volume":"313","author":"Weeraratna","year":"2007","journal-title":"Exp Cell Res"},{"key":"2023082804052294200_ref71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3233\/JAD-200506","article-title":"Subcutaneous administration of AMD3100 into mice models of Alzheimer\u2019s disease ameliorated cognitive impairment, reduced neuroinflammation, and improved pathophysiological markers","volume":"78","author":"Gavriel","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"2023082804052294200_ref72","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.092013799","article-title":"Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor","volume":"99","author":"Lu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023082804052294200_ref73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2007.07.001","article-title":"Reduced CXCL12\/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease","volume":"28","author":"Parachikova","year":"2007","journal-title":"Neurobiol Dis"},{"key":"2023082804052294200_ref74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","article-title":"CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson\u2019s disease","volume":"16","author":"Shimoji","year":"2009","journal-title":"Neurotox Res"},{"key":"2023082804052294200_ref75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12974-016-0587-6","article-title":"Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS","volume":"13","author":"Rabinovich-Nikitin","year":"2016","journal-title":"J Neuroinflammation"},{"key":"2023082804052294200_ref76","doi-asserted-by":"crossref","first-page":"e0247707","DOI":"10.1371\/journal.pone.0247707","article-title":"CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats","volume":"16","author":"Mason","year":"2021","journal-title":"PloS One"},{"key":"2023082804052294200_ref77","doi-asserted-by":"crossref","first-page":"166597","DOI":"10.1016\/j.bbadis.2022.166597","article-title":"CXCR4 knockout induces neuropathological changes in the MPTP-lesioned model of Parkinson\u2019s disease","volume":"1869","author":"Ma","year":"2023","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"2023082804052294200_ref78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/156802610790232251","article-title":"Successful applications of computer aided drug discovery: moving drugs from concept to the clinic","volume":"10","author":"Talele","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"2023082804052294200_ref79","doi-asserted-by":"crossref","first-page":"348111","DOI":"10.3389\/fchem.2018.00057","article-title":"Computer-aided drug design in epigenetics","volume":"6","author":"Lu","year":"2018","journal-title":"Front Chem"},{"key":"2023082804052294200_ref80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1747-0285.2012.01317.x","article-title":"1-Benzyl-1,2,3,4-tetrahydro-\u03b2-carboline as channel blocker of N-methyl-D-aspartate receptors","volume":"79","author":"Espinoza-Moraga","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"2023082804052294200_ref81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejmech.2016.09.057","article-title":"Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur J Med Chem"},{"key":"2023082804052294200_ref82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/826047","article-title":"In silico investigation of flavonoids as potential trypanosomal nucleoside hydrolase inhibitors","volume":"2015","author":"Ha","year":"2015","journal-title":"Adv Bioinformatics"},{"key":"2023082804052294200_ref83","doi-asserted-by":"crossref","first-page":"e00480","DOI":"10.1002\/prp2.480","article-title":"Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling","volume":"7","author":"Fjelldal","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"2023082804052294200_ref84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12868-017-0394-8","article-title":"In silico repurposing of antipsychotic drugs for Alzheimer\u2019s disease","volume":"18","author":"Kumar","year":"2017","journal-title":"BMC Neurosci"},{"key":"2023082804052294200_ref85","first-page":"367","article-title":"Memantine: a review of studies into its safety and efficacy in treating Alzheimer\u2019s disease and other dementias","volume":"4","author":"Thomas","year":"2009","journal-title":"Clin Interv Aging"},{"key":"2023082804052294200_ref86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/21553769.2013.815137","article-title":"Design of potent inhibitors of acetylcholinesterase using morin as the starting compound","volume":"6","author":"Remya","year":"2012","journal-title":"Front Life Sci"},{"key":"2023082804052294200_ref87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10799893.2019.1641821","article-title":"In silico study combining QSAR, docking and molecular dynamics simulation on 2,4-disubstituted pyridopyrimidine derivatives","volume":"39","author":"Tadayon","year":"2019","journal-title":"J Recept Signal Transduct Res"},{"key":"2023082804052294200_ref88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2012.09.030","article-title":"Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer\u2019s disease: synthesis, biological assessment, and molecular modeling","volume":"57","author":"Samadi","year":"2012","journal-title":"Eur J Med Chem"},{"key":"2023082804052294200_ref89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/mol.118.114348","article-title":"Derivatives of piperazines as potential therapeutic agents for Alzheimer\u2019s disease","volume":"95","author":"Popugaeva","year":"2019","journal-title":"Mol Pharmacol"},{"key":"2023082804052294200_ref90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12539-019-00352-9","article-title":"Revealing the mechanism of EGCG, genistein, rutin, quercetin, and silibinin against hIAPP aggregation via computational simulations","volume":"12","author":"Wang","year":"2020","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"2023082804052294200_ref91","doi-asserted-by":"crossref","first-page":"88442","DOI":"10.3389\/fnmol.2014.00051","article-title":"In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2","volume":"7","author":"Vancraenenbroeck","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"2023082804052294200_ref92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2013.06.021","article-title":"Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer\u2019s disease","volume":"67","author":"Samadi","year":"2013","journal-title":"Eur J Med Chem"},{"key":"2023082804052294200_ref93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7043213","article-title":"Flavonoids as therapeutic agents in Alzheimer\u2019s and Parkinson\u2019s diseases: a systematic review of preclinical evidences","volume":"2018","author":"De Andrade Teles","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"2023082804052294200_ref94","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s11064-013-1070-8","article-title":"(2S)-5, 2\u2032, 5\u2032-Trihydroxy-7-methoxyflavanone, a natural product from Abacopteris penangiana, presents neuroprotective effects in vitro and in vivo","volume":"38","author":"Wei","year":"2013","journal-title":"Neurochem Res"},{"key":"2023082804052294200_ref95"},{"key":"2023082804052294200_ref96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.04.008","article-title":"Morin reverses neuropathological and cognitive impairments in APPswe\/PS1dE9 mice by targeting multiple pathogenic mechanisms","volume":"108","author":"Du","year":"2016","journal-title":"Neuropharmacology"},{"key":"2023082804052294200_ref97","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1016\/j.bmc.2012.09.005","article-title":"Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer\u2019s disease","volume":"20","author":"Roy","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"2023082804052294200_ref98","article-title":"Virtual screening and biological evaluation of piperazine derivatives as human acetylcholinesterase inhibitors","volume":"2013","author":"Varadaraju","year":"2013","journal-title":"Int J Alzheimers Dis"},{"key":"2023082804052294200_ref99","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/DDDT.S103511","article-title":"Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats","volume":"11","author":"Venkata","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"2023082804052294200_ref100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2017.07.019","article-title":"Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease","volume":"298","author":"West","year":"2017","journal-title":"Exp Neurol"},{"key":"2023082804052294200_ref101","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cbi.2006.12.006","article-title":"Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach","volume":"171","author":"Kapetanovic","year":"2008","journal-title":"Chem Biol Interact"},{"key":"2023082804052294200_ref102","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm Res"},{"key":"2023082804052294200_ref103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/138620712799361825","article-title":"Computer-aided drug design: lead discovery and optimization","volume":"15","author":"Xiang","year":"2012","journal-title":"Comb Chem High Throughput Screen"},{"key":"2023082804052294200_ref104","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10822-010-9393-x","article-title":"Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach","volume":"24","author":"Neves","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"2023082804052294200_ref105","doi-asserted-by":"crossref","first-page":"e78744","DOI":"10.1371\/journal.pone.0078744","article-title":"Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists","volume":"8","author":"Vinader","year":"2013","journal-title":"PloS One"}],"container-title":["Integrative Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ib\/article-pdf\/doi\/10.1093\/intbio\/zyad012\/51260831\/zyad012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ib\/article-pdf\/doi\/10.1093\/intbio\/zyad012\/51260831\/zyad012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:20:09Z","timestamp":1693196409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ib\/article\/doi\/10.1093\/intbio\/zyad012\/7251310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":105,"URL":"https:\/\/doi.org\/10.1093\/intbio\/zyad012","relation":{},"ISSN":["1757-9708"],"issn-type":[{"value":"1757-9708","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023]]},"published":{"date-parts":[[2023]]},"article-number":"zyad012"}}